MFDS to support Phase III trials of domestic COVID-19 Txs
By Lee, Tak-Sun | translator Alice Kang
21.11.03 16:18:57
가나다라
0
The meeting were held to support COVID-19 treatment candidates…. “Will make efforts to address the companies’ difficulties in addition to approval review support."
The Ministry of Food and Drug Safety has been supporting domestic companies that have entered Phase III trials for their domestic COVID-19 treatments through its ‘Development-focused Support Council.'
The three items currently approved for Phase III trials and supported by the Support Council are: Chong Kun Dang’s ‘Nafabeltan (nafamostat),’ Daewoong Pharmaceutical's ‘Foistar(camostat),’ and Shin Poong Pharmaceutical’s ‘ Pyramax (pyronaridine/artesunate).’
The news was shared at an ‘Online briefing session regarding 2021 2H drug reviews ’ that MFDS held on the 3rd.
Kyung-sook Choi, a researcher of the Oncology and Antimicrobial Products Division, said, “W
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)